The French drug maker, which develops vaccines and otherpharmaceuticals and is currently working on a vaccine to combatbird flu, selected the two-story site because it gave the company afull, stand-alone building just blocks from MIT, a broker involvedin the sale who did not want to be identified tells GlobeSt.com.The company is currently located at 26 Lansdowne St. here.

Porter McMillian, senior vice president of US Science &Medical Affairs for sanofi-aventis, says in a statement theexpansion along with the developing technologies from nearbycolleges and universities will help the firm meet its research anddevelopment goals. Dan Loughlin with the Staubach Co. in New Jerseyand Greg Zais with Staubach in Boston brokered the deal for thetenant. The building's owner, Biomed Realty Trust, wasself-represented.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Boston
Leasing
National
Office